Advent Life Sciences

‘Katja and her team at Scius provided Advent with comprehensive strategic communications advice, and ensured Advent’s key messages about investing in outstanding, early-stage science to nurture innovative companies were successfully delivered, resulting in excellent coverage of our two new funds in top tier life science media publications. We were particularly impressed with the level of commitment and responsive to achieving outstanding results.’

Laura Lane
Associate at Advent Life Sciences

Objectives

Promote key messages relating to the raising of Advent’s two funds and its investment objectives
Highlight the experience of the life sciences team, and the rational for collaborating with Harrington Discovery Institute (HDI) and the investment from British Patient Capital (BPC)
Raise awareness of the team’s track record of successful fundraisings, exits and value creation using portfolio company case studies

Strategy

Drafting announcement and key messages that appropriately reflect the strategy and rationale for the two funds
Liaising with key stakeholders including BPC and HDI to co-ordinate timings, sign-off and potential quotes for the announcement
Drafting Q&A and ensuring key stakeholders who may be asked to comment in the press agree on the responses
Pre-briefing target journalists under embargo and setting up one-on-one briefings in advance of the news, with further media follow up on day of release

Results

Extensive global trade media coverage (BioCentury, BioWorld, Endpoints, Fierce Biotech) and many private equity publications (Unquote, Markets Insider, PitchBook, Public Equity News, Real Deals)